Trevi Therapeutics, Inc. TRVI
NASDAQ · United States · Health Technology
$14.49+0.17 (+1.19%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.11 | -0.11 | -0.5% | $0 | — | -0.8%$18.65→$18.51 |
| Q1 2026 | 2026-05-05 | -0.09 | -0.07 | -28.6% | — | — | -0.8%$14.38→$14.26 |
| Q4 2025 | 2026-03-17 | -0.06 | -0.10 | +40.0% | — | — | -4.2%$11.16→$10.69 |
| Q3 2025 | 2025-11-13 | -0.08 | -0.10 | +20.0% | — | — | -4.1%$11.85→$11.37 |
| Q4 2024 | 2025-03-18 | -0.11 | -0.12 | +8.3% | — | — | — |
| Q4 2023 | 2024-03-20 | -0.08 | -0.09 | +11.1% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.